Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia

Podobne knjige/članki

• Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
  od: Keyuan Zhang, et al.
  Izdano: (2023-10-01)
• Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN
  od: Naveen Pemmaraju, et al.
  Izdano: (2025-05-01)
• Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in <i>TP53</i>-mutated myelodysplastic syndromes
  od: Mahmood Aldapt, et al.
  Izdano: (2026-01-01)
• Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients
  od: Jingyi Shen, et al.
  Izdano: (2025-02-01)
• P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX
  od: Jian Zhang, et al.
  Izdano: (2023-08-01)